Mallinckrodt to Buy Questcor Pharmaceuticals

Mallinckrodt agreed to buy Questcor Pharmaceuticals for about $5.2 billion in cash and stock, in a deal expected to expand the scale and diversification of the specialty pharmaceutical company.

Leave a Reply

Your email address will not be published. Required fields are marked *